Bio Path Holdings Inc logo

Bio Path Holdings Inc Share Price (NASDAQ: BPTH)

▲

-0.18

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 21 Feb 2025

Check the interactive Bio Path Holdings Inc Stock chart to analyse performance

Bio Path Holdings Inc Key Stats

Check Bio Path Holdings Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.185
Open
$0.19
Market Capitalization
$1.2M
Today's Volume
$136.6K
Revenue TTM
$0.0
EBITDA
$-12.4M
Earnings Per Share (EPS)
$-8.34
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1159.74%

Global Institutional Holdings in Bio Path Holdings Inc

  • Name

    Holdings %

  • Apollon Wealth Management, LLC

    0.26%

  • Geode Capital Management, LLC

    0.24%

  • Vanguard Group Inc

    0.23%

  • Citadel Advisors Llc

    0.19%

  • Tower Research Capital LLC

    0.06%

  • UBS Group AG

    0.05%

Analyst Recommendation on Bio Path Holdings Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Bio Path Holdings Inc(by analysts ranked 0 to 5 stars)

About Bio Path Holdings Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.
Organization
Bio Path Holdings Inc
Employees
10
CEO
Mr. Peter H. Nielsen MBA
Industry
Health Technology

Key Management of Bio Path Holdings Inc

NameTitle
Mr. Peter H. Nielsen MBA
Co-Founder, Chairman of the Board, CEO, President, CFO & Treasurer
Mr. Douglas P. Morris
Co-Founder, Director of Investor Relations, Secretary & Director
Mr. Michael Hickey M.B.A.
VP of Clinical Operations
Mr. Anthony Price MBA
Senior Vice President of Finance, Accounting & Administration
Dr. Ana Tari Ashizawa M.B.A., MBA, Ph.D.
Senior Vice President of Research, Development & Clinical Design

Important FAQs about investing in BPTH Stock from India :

What is Bio Path Holdings Inc share price today?

Bio Path Holdings Inc share price today is as on at the close of the market. Bio Path Holdings Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Bio Path Holdings Inc share?

Bio Path Holdings Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Bio Path Holdings Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Bio Path Holdings Inc Stock (BPTH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bio Path Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bio Path Holdings Inc Shares .

What is the minimum amount required to buy Bio Path Holdings Inc Stock (BPTH) from India?

Indian investors can start investing in Bio Path Holdings Inc (BPTH) shares with as little as ₹87.7613 or $1 (as of September 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹877.61 in Bio Path Holdings Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025). Learn more about fractional shares .

What are the returns that Bio Path Holdings Inc has given to Indian investors in the last 5 years?

Bio Path Holdings Inc stock has given 0.0% share price returns and 19.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?